(Stroke. 2000;31:2623.)
© 2000 American Heart Association, Inc.
Original Contributions |
From the Departments of Medicine (M.R.D.T., M.T.S., R.R.S., S.H.), Neurology (R.L.S.), and Public Health (Epidemiology) (R.L.S.), Sergievsky Center, Columbia-Presbyterian Medical Center, New York, NY.
| Abstract |
|---|
|
|
|---|
MethodsWe performed transesophageal echocardiography in 152 patients aged >59 years with acute ischemic stroke (76 men and 76 women) and in 152 control subjects of similar age (70 men and 82 women). Odds ratios (ORs) for ischemic stroke with 95% CIs for different plaque thickness definitions were calculated for the overall group and separately for men and women by logistic regression analysis after adjusting for age, arterial hypertension, and hypercholesterolemia.
ResultsAortic plaques
4 mm were significantly more
frequent in men than in women (31.5% versus 20.3%, respectively;
P=0.025) and were associated with ischemic
stroke in both men (adjusted OR 6.0, CI 2.1 to 16.8) and women
(adjusted OR 3.2, CI 1.2 to 8.8). However, plaques 3 to 3.9 mm in
thickness had a significant association with stroke in women (adjusted
OR 4.8, CI 1.7 to 15.0) but not in men (adjusted OR 0.8, CI 0.2 to
3.0). Plaques <3 mm were not associated with a significantly
increased stroke risk for either sex.
ConclusionsSmaller aortic plaques are significantly associated with ischemic stroke in women but not in men. If the increased prevalence of smaller plaques in women is confirmed to be associated with increased risk for embolic stroke, different cutoff points may have to be adopted in men and women for risk stratification and for decisions regarding medical intervention.
Key Words: aortic arch cerebrovascular disorders echocardiography, transesophageal stroke, ischemic
| Introduction |
|---|
|
|
|---|
| Subjects and Methods |
|---|
|
|
|---|
Results of the analysis of the association between aortic atheroma and ischemic stroke in the same population have been published previously.11 The present article reports on a subset analysis by gender and with the application of various atheroma thickness cutoffs.
Diagnostic Evaluation
The presence of cardiovascular risk factors was
ascertained by means of interview and review of medical records.
Arterial hypertension was defined as blood pressure
>160/90 mm Hg during the admission, a positive history, or the
presence of antihypertensive treatment. Diabetes mellitus was defined
on the basis of positive history or appropriate medical treatment.
Hypercholesterolemia was defined as a total
serum cholesterol >200 mg/dL at admission or the presence
of appropriate medical treatment.
Neuroimaging studies in stroke patients consisted of head CT or MRI, carotid duplex Doppler examination, transcranial Doppler ultrasound examination of the anterior and middle cerebral arteries and basilar arteries, and cerebral angiography when clinically indicated.
Cardiac evaluation included 12-lead ECG, transthoracic echocardiography, and biplane or multiplane TEE with use of a 5-MHz transducer.
Based on the diagnostic evaluation described above, stroke diagnostic subtypes were defined by a neurologist aware of the results of all the diagnostic procedures but not of the results of TEE.
Determination of plasma fibrinogen levels was performed in a subgroup of 70 stroke patients.
Detection of Aortic Plaques
The aorta was imaged in both transverse and longitudinal
views.12 The proximal aorta was defined as the portion of
the vessel between the aortic valve and the takeoff of the left
subclavian artery. Plaques were defined as discrete protrusions of the
intimal surface with different appearance and echogenicity from the
adjacent intact portion. The thickness of the plaque was measured
perpendicular to the lumen of the vessel by means of apposite computer
software. In the case of multiple plaques, the thickest was considered
for stroke-risk analysis. The presence of ulcerations or mobile
components was recorded.7 The interpretation of the
studies was performed by a single experienced observer, blinded to
case-control status. A reproducibility analysis at our
laboratory for plaque thickness measurement showed a mean variability
of 0.21 mm. An example of plaque measurement is provided in the
Figure
.
|
Statistical Analysis
Differences between mean values were assessed by Student
t test for unpaired data, and differences between
proportions were assessed by
2 test, replaced
by Fisher exact test in the case of an expected cell count <5.
Unadjusted odds ratios for stroke of different plaque thicknesses (2 to
2.9 mm, 3 to 3.9 mm, and
4 mm) were calculated by
means of logistic regression analysis (SAS statistical package,
version 6.12) for the overall group and separately for each gender.
Adjusted odds ratios for different plaque thicknesses were then
calculated by multivariate logistic regression
analysis, including variables identified as associated with
stroke by univariate analysis (arterial
hypertension and hypercholesterolemia) and age
(biologically relevant variable) as independent variables. The
adjustment for hypertension and
hypercholesterolemia as dichotomous
(present versus absent) or continuous (blood pressure values and
serum cholesterol levels) variables did not
significantly affect the risk estimates. Odds ratios obtained with
dichotomous variable definitions will be presented in
Results.
| Results |
|---|
|
|
|---|
|
Among stroke patients, the stroke mechanism was considered to be atherosclerotic in 22%, cardioembolic in 28%, and lacunar in 12%; the remaining 38% were considered to have had a cryptogenic stroke.
A patent foramen ovale was found in 37 stroke patients (24.5%), without significant differences between women (18 patients [24%]) and men (19 patients [25%]).
In the 70 stroke patients in the present study who had serum fibrinogen levels tested, abnormal levels were found in a significantly higher proportion of women (28 [80%] of 35 patients) than men (17 [49%] of 35 patients, P=0.006).
Frequency of Aortic Plaques
Aortic plaques of any size were found in >70% of the study
population (224 of 304 subjects), without significant differences
between men (108 [74%] of 146 subjects) and women (113 [72%] of
158 subjects). Plaques
4 mm in thickness were significantly more
frequent in men than in women (31.5% versus 20.3%, respectively;
P=0.025). Plaques between 2 and 3.9 mm in thickness
tended to be more frequent in women than in men (51.3% versus 41.8%,
respectively; P=0.13). Mean plaque thickness tended to be
greater in men than in women (0.33±0.26 versus 0.29±0.23 mm,
respectively; P=0.15). Ulcerated or mobile plaque components
were found in 38 (12.5%) of 304 subjects, without significant
differences between men (22 [15.0%] of 146 subjects) and women (16
[10.1%] of 158 subjects, P=0.2). All ulcerated or mobile
components were observed in plaques
4 mm in thickness.
Association Between Aortic Plaques and Ischemic Stroke
The association between aortic plaque thickness and stroke for the
overall group (ie, regardless of the gender of the patient) and for
each gender subgroup is reported in Table 2
. Plaques
4 mm in thickness were
strongly associated with stroke in both the overall group and in each
gender subgroup. The significant association persisted after adjustment
for other stroke risk factors. Plaques 3 to 3.9 mm in thickness
were also significantly associated with ischemic stroke in the
overall group, but breakdown of the data by gender revealed that the
association was present only in women. This remained true after
adjustment for other stroke risk factors. Plaques of <3 mm in
thickness were not found to be associated with ischemic stroke
in either sex.
|
Ulcerated or mobile plaques were significantly more frequent in stroke patients than in control subjects in the overall group (22.4% versus 2.6%, respectively; P=0.001) and in both men (27.6% versus 1.4%, respectively; P=0.001) and women (17.1% versus 3.7%, respectively; P=0.001). The small number of subjects with ulcerated or mobile lesions in the control group prevented the performance of a multivariate analysis.
| Discussion |
|---|
|
|
|---|
Why smaller plaques are significantly associated with ischemic
stroke in women but not in men is not immediately clear. It should be
noted that the present study documented an epidemiological
association between smaller plaques and stroke in women but did not
seek to establish a causative link between these plaques and the stroke
mechanism in individual patients. Therefore, the actual role of these
smaller plaques as a source for embolic stroke is not determined in the
present study. Plaque thickness may be a marker of other underlying
processes (such as extensive small-vessel
atherosclerosis) that may play different roles in the 2
genders. It has been suggested that the greater stroke risk associated
with larger plaques may be due to the more frequent presence on them of
thrombotic material, which could be responsible for both the greater
plaque thickness and its increased embolic potential.5
Larger plaques have in fact been shown to be highly dynamic lesions, in
which thrombus formation and resolution continuously
occur.13 Our findings are not incompatible with this
hypothesis, because all of the ulcerated or mobile plaque components,
suggestive of previous or current thrombus presence, were observed in
the present study in plaques
4 mm thick. These complex
lesions were strongly associated with stroke in both men and women in
the present study as well as in previous studies.14 15
As we have recently reported for the same population,11
large complex plaques appear as a possible culprit for stroke, whereas
equally large but noncomplex lesions are associated with only a modest
increase in stroke risk. This combined information seems to suggest
that although complex morphological features of the plaque may be
directly involved in the stroke mechanism, plaque thickness in itself
may primarily be a marker of increased risk, the underlying reasons for
which may somewhat differ between men and women. Cofactors may exist
(such as hypercoagulable states or lipid abnormalities) that may be
differently distributed between men and women. In a subgroup of 70
stroke patients in the present study who had serum fibrinogen
levels tested, abnormal levels were found in a significantly higher
proportion of women (28 [80%] of 35 patients) than men (17 [49%]
of 35 patients, P=0.006). Elevated fibrinogen levels have
been shown to be a risk factor for cardiovascular
disease and stroke16 17 18 19 20 21 22 and to be associated with
the degree of carotid stenosis,23 24 25 26 especially
in the elderly.27 Atherogenic effects of fibrinogen have
been described, possibly as the result of its interactions with some
lipoproteins, such as lipoprotein(a)28 and
HDL.29 Finally, fibrinogen levels have been shown to be
associated with the severity of aortic atherosclerosis
detected by TEE,30 31 as in the present study. The
study of hemostatic markers and lipoprotein profiles as potential
cofactors might allow further insight into the mechanism of the
association between aortic plaques and stroke and might possibly
explain some of the gender differences we observed.
The therapeutic options in patients with ischemic stroke and proximal aortic plaques remain to be determined. Anticoagulation appears indicated in the case of complex lesions, because there is evidence that it may reduce the stroke recurrence rate.32 33 Preliminary evidence has also been reported of a beneficial effect of anticoagulation in patients with large noncomplex plaques,34 but more data are needed to confirm this indication. Aortic arch endarterectomy in patients with high-risk lesions has been shown to be associated with considerable morbidity and mortality35 and should be reserved for selected cases. The present study suggests that differences in risk between men and women should also be kept in mind and that further investigation is needed, along with data on possible cofactors of increased risk and potential alternative treatments (eg, antiplatelet agents and lipid-lowering drugs). Estrogen replacement therapy could also be considered in postmenopausal women, because it has been shown to reduce both fibrinogen and LDL cholesterol levels.36
The present study has some limitations. Doppler examination of the carotid arteries was not performed in control subjects; therefore, its effect on the risk of stroke in men and women could not be factored into the analysis. However, among stroke patients, no significant difference was observed in the frequency of carotid stenosis between men and women, making the possibility of a significant effect of carotid disease as a confounding factor of the association between aortic plaque and stroke unlikely. Control subjects were patient controls rather than normal volunteers. However, clinical indications for TEE did not differ between men and women; therefore, the patients underlying clinical conditions should not have affected the intergender analyses performed.
In conclusion, the present study demonstrated that differences exist between men and women in the relationship between aortic plaque thickness and risk of ischemic stroke. This observation and the possible need for different cutoff points of increased risk should be kept in mind when assessing stroke risk in individual patients. The significance of these differences and their explanation require further investigation.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received April 24, 2000; revision received August 7, 2000; accepted August 7, 2000.
| References |
|---|
|
|
|---|
2. Katz ES, Tunick PA, Rusinek H, Ribakove G, Spencer FC, Kronzon I. Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol. 1992;29:7077.
3.
Toyoda K, Yasaka M, Nagata S, Yamaguchi T. Aortogenic
embolic stroke: a transesophageal
echocardiographic approach. Stroke. 1992;23:10561061.
4. Davila-Roman VG, Barzilai B, Wareing TH, Murphy SF, Schechtman KB, Kouchoukos NT. Atherosclerosis of the ascending aorta: prevalence and role as an independent predictor of cerebrovascular events in cardiac patients. Stroke. 1994;25:20102016.[Abstract]
5.
Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M,
Besson G, Chauvel C, Touboul PJ, Bousser MG. Atherosclerotic disease of
the aortic arch and the risk of ischemic stroke. N
Engl J Med. 1994;331:14741479.
6. Jones EF, Kalman JM, Calafiore P, Tonkin AM, Donnan GA. Proximal aortic atheroma: an independent risk factor for cerebral ischemia. Stroke. 1995;26:218224.
7.
Di Tullio MR, Sacco RL, Gersony D, Nayak H, Weslow RG,
Kargman DE, Homma S. Aortic atheromas and acute
ischemic stroke: a transesophageal
echocardiographic study in an ethnically mixed
population. Neurology. 1996;46:15601566.
8. Tunick PA, Rosenzweig BP, Katz ES, Freedberg RS, Peres JL, Kronzon I. High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol. 1994;23:10851090.[Abstract]
9.
The French Study of Aortic Plaques in Stroke Group.
Atherosclerotic disease of the aortic arch as a risk factor for
recurrent ischemic stroke. N Engl J Med. 1996;334:12161221.
10.
Mitusch R, Doherty C, Wucherpfennig H, Memmesheimer C,
Tepe C, Stierle U, Kessler C, Sheikzadeh A. Vascular events during
follow-up in patients with aortic atherosclerosis.
Stroke. 1997;28:3639.
11. Di Tullio MR, Sacco RL, Savoia MT, Sciacca RR, Homma S. Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J. 2000;139:329336.[Medline] [Order article via Infotrieve]
12. Di Tullio MR, Sacco RL, Homma S. Ultrasound examination of the aortic arch in stroke. In: Primer on Cerebrovascular Diseases. San Diego, Calif: Academic Press; 1996:628634.
13. Montgomery DH, Ververis JJ, McGorisk G, Frohwein S, Martin RP, Taylor WR. Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol. 1996;27:95101.[Abstract]
14. Stone DA, Hawke MW, LaMonte M, Kittner SJ, Acosta J, Corretti M, Sample C, Price TR, Plotnick GD. Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J. 1995;130:105108.[Medline] [Order article via Infotrieve]
15.
Cohen A, Tzourio C, Bertrand B, Chauvel C, Bousser MG,
Amaranco P. Aortic plaque morphology and vascular events: a follow-up
study in patients with ischemic stroke. Circulation. 1997;96:38383841.
16. Qizilbash N. Fibrinogen and cerebrovascular disease. Eur Heart J. 1995;16(suppl A):4245.
17. Kannel WB, DAgostino RB, Belanger AJ. Update of fibrinogen as a cardiovascular risk factor. Ann Epidemiol. 1992;2:457466.[Medline] [Order article via Infotrieve]
18.
Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N,
Nieto FJ, Rasmussen ML, Wu KK. Prospective study of markers of
hemostatic function with risk of ischemic stroke: the
Atherosclerosis Risk in Communities (ARIC) Study
Investigators. Circulation. 1999;100:736742.
19. Held C, Hjemdahl P, Hakan Wallen N, Bjorkander I, Forslund L, Wiman B, Rehnqvist N. Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris: results from the APSIS study: the Angina Prognosis Study in Stockholm Atherosclerosis. 2000;148:179188.[Medline] [Order article via Infotrieve]
20. Mazoyer E, Drouet L, Soria C, Fruchard JC, Pellerin A, Arcan JC, Tobelem G. Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. Thromb Res. 1999;95:163176.[Medline] [Order article via Infotrieve]
21.
Tracy RP, Arnold AM, Ettinger W, Fried L, Meilahn E,
Savage P. The relationship of fibrinogen and factors VII and VIII to
incident cardiovascular disease and death in the
elderly: results from the Cardiovascular Health Study.
Arterioscler Thromb Vasc Biol. 1999;19:17761783.
22.
Ma J, Hennekens CH, Ridker PM, Stampfler MJ. A
prospective study of fibrinogen and risk of myocardial infarction in
the Physicians Health Study. J Am Coll Cardiol. 1999;33:13471352.
23.
Levenson J, Giral P, Razavian M, Gariepy J, Simon A.
Fibrinogen and silent atherosclerosis in subjects with
cardiovascular risk factors. Arterioscler Thromb
Vasc Biol. 1995;15:12631268.
24. Heinrich J, Schulte H, Schonfeld R, Kohler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 1995;73:374379.[Medline] [Order article via Infotrieve]
25. Agewall S, Wikstrand J, Suurkula M, Tengborn L, Fagerberg B. Carotid artery wall morphology, haemostatic factors and cardiovascular disease: an ultrasound study in men at high and low risk for atherosclerotic disease. Blood Coagul Fibrinolysis. 1994;5:895904.[Medline] [Order article via Infotrieve]
26.
Dobs AS, Nieto FJ, Szklo M, Barnes R, Sharrett AR, Ko
WJ. Risk factors for popliteal and carotid wall thicknesses in the
Atherosclerosis Risk in Communities (ARIC) Study.
Am J Epidemiol. 1999;150:10551067.
27.
Willeit J, Kiechl S. Prevalence and risk factors of
asymptomatic extracranial carotid artery
atherosclerosis: a population-based study.
Arterioscler Thromb. 1993;13:661668.
28.
Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger
G, Jarosch E, Mair A. Lipoprotein (a) and asymptomatic
carotid artery disease: evidence of a prominent role in the evolution
of advanced carotid plaques: the Bruneck Study. Stroke. 1995;26:15821587.
29.
Szirmai IG, Kaimondi A, Magyar H, Juhasz C. Relation of
laboratory and clinical variables to the grade of carotid
atherosclerosis. Stroke. 1993;24:18111816.
30. Triboulloy C, Peltier M, Colas L, Senni M, Ganry O, Rey JL, Lesbre JP. Fibrinogen is an independent marker for aortic atherosclerosis. Am J Cardiol. 1998;81:321326.[Medline] [Order article via Infotrieve]
31. Di Tullio MR, Savoia MT, Yip N, Sciacca RR, Mendoza LM, Thompson EV, Titova I, Nahar T, Mihalatos D, Sacco RL, et al. Increased frequency of fibrinogen elevation in elderly stroke patients with large aortic arch atheromas. Cerebrovasc Dis. 1997;7:31. Abstract.
32.
Dressler FA, Craig WR, Castello R, Labovitz AJ. Mobile
aortic atheroma and systemic emboli: efficacy of
anticoagulation and influence of plaque morphology on recurrent stroke.
J Am Coll Cardiol. 1998;31:134138.
33.
The Stroke Prevention in Atrial Fibrillation
Investigators Committee on Echocardiography.
Transesophageal echocardiographic
correlates of thromboembolism in high-risk patients with
nonvalvular atrial fibrillation. Ann Intern Med. 1998;128:639647.
34.
Ferrari E, Vidal R, Chevallier T, Baudouy M.
Atherosclerosis of the thoracic aorta and aortic debris
as a marker of poor prognosis: benefit of oral anticoagulants.
J Am Coll Cardiol. 1999;33:13171322.
35. Stern A, Tunick PA, Culliford AT, Lachmann J, Baumann FG, Kanchuger MS, Marschall K, Shah A, Grossi E, Kronzon I. Protruding aortic arch atheromas: risk of stroke during heart surgery with and without aortic arch endarterectomy. Am Heart J. 1999;138:746752.[Medline] [Order article via Infotrieve]
36.
De Valk-de Roo GW, Stehouwer CD, Mejer P, Mijatovic V,
Kluft C, Kenemans P, Cohen F, Watts S, Netelenbos C. Both raloxifene
and estrogen reduce major cardiovascular risk factors
in healthy postmenopausal women: a 2-year, placebo-controlled study.
Arterioscler Thromb Vasc Biol. 1999;19:29933000.
This article has been cited by other articles:
![]() |
T. Goto, T. Baba, A. Ito, K. Maekawa, and T. Koshiji Gender Differences in Stroke Risk Among the Elderly After Coronary Artery Surgery Anesth. Analg., May 1, 2007; 104(5): 1016 - 1022. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Meissner, B. K. Khandheria, S. G. Sheps, G. L. Schwartz, D. O. Wiebers, J. P. Whisnant, J. L. Covalt, T. M. Petterson, T. J.H. Christianson, and Y. Agmon Atherosclerosis of the aorta: Risk factor, risk marker, or innocent bystander?: A prospective population-based transesophageal echocardiography study J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1018 - 1024. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Roquer, A. R. Campello, and M. Gomis Sex Differences in First-Ever Acute Stroke Stroke, July 1, 2003; 34(7): 1581 - 1585. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S.V. Elkind, R. Sciacca, B. Boden-Albala, S. Homma, and M. R. Di Tullio Leukocyte Count Is Associated With Aortic Arch Plaque Thickness Stroke, November 1, 2002; 33(11): 2587 - 2592. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sugioka, T. Hozumi, R. R. Sciacca, Y. Miyake, I. Titova, G. Gaspard, R. L. Sacco, S. Homma, and M. R. Di Tullio Impact of Aortic Stiffness on Ischemic Stroke in Elderly Patients Stroke, August 1, 2002; 33(8): 2077 - 2081. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2000 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |